Is TRINITY BIOTECH PLC (TRIB) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 731.7% / 30% | 37.5% / 30% | 106.0% / 30% | 0.0% / 5% | ✗ NOT HALAL |
| DJIM | 731.7% / 33% | 37.5% / 33% | 106.0% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| MSCI | 97.6% / 33% | 5.0% / 33% | 14.1% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| S&P | 731.7% / 33% | 37.5% / 33% | 106.0% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| FTSE | 97.6% / 33% | 5.0% / 33% | 14.1% / 50% | 0.0% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 36.8% | |
| Operating Margin | -3.6% | |
| Net Margin | -75.9% | |
| Return on Assets (ROA) | -9.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$4M |
| Free Cash Flow | -$14M |
| Total Debt | $101M |
| Current Ratio | 1.0 |
| Total Assets | $103M |
Price & Trading
| Last Close | $0.61 |
| 50-Day MA | $0.74 |
| 200-Day MA | $0.91 |
| Avg Volume | 419K |
| Beta | 0.7 |
|
52-Week Range
$0.48
| |
About TRINITY BIOTECH PLC (TRIB)
Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. In addition, the company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc It has a collaboration agreement with a bioinformatics company to conduct analysis on clinical trial data for EpiCapture, a PCR-based epigenetic liquid biopsy test for monitoring the risk of prostate cancer progressing to aggressive forms of the disease. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is TRINITY BIOTECH PLC (TRIB) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), TRINITY BIOTECH PLC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is TRINITY BIOTECH PLC's debt ratio?
TRINITY BIOTECH PLC's debt ratio is 731.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 97.6%.
What are TRINITY BIOTECH PLC's key financial metrics?
TRINITY BIOTECH PLC has a market capitalization of $11M, and revenue of $62M. The company maintains a gross margin of 36.8% and a net margin of -75.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.